These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29568094)

  • 1. Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis.
    Suárez-González J; Martínez-Laperche C; Martínez N; Rodríguez-Macías G; Kwon M; Balsalobre P; Carbonell D; Chicano M; Serrano D; Triviño JC; Piris MÁ; Gayoso J; Díez-Martín JL; Buño I
    Leukemia; 2018 Aug; 32(8):1822-1826. PubMed ID: 29568094
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
    Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia.
    Ock CY; Seo H; Kim DY; Min BJ; Park Y; Cheong HS; Kim HL; Song EY; Kim I; Yoon SS; Kim JH; Koh Y
    Leuk Lymphoma; 2019 Jul; 60(7):1775-1781. PubMed ID: 30507323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
    Eefting M; von dem Borne PA; de Wreede LC; Halkes CJ; Kersting S; Marijt EW; Veelken H; Falkenburg JF
    Haematologica; 2014 Apr; 99(4):751-8. PubMed ID: 24241493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
    Ruiz-Delgado GJ; León Peña AA; Gómez-de-León A; Ruiz-Argüelles GJ
    Hematology; 2016 Sep; 21(8):470-3. PubMed ID: 26914843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.
    Tachibana T; Matsumoto K; Tanaka M; Hagihara M; Motohashi K; Yamamoto W; Ogusa E; Koyama S; Numata A; Tomita N; Taguchi J; Fujisawa S; Kanamori H; Nakajima H
    Leuk Lymphoma; 2017 Jun; 58(6):1403-1411. PubMed ID: 27739916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation.
    Gratwohl A; Ruiz de Elvira C; Gratwohl M; Greinix HT; Duarte R;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1145-1146. PubMed ID: 27032302
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia.
    Mahmood S; Lim ZY; Benton E; du Vivier A; Bhogal B; Mufti GJ; Pagliuca A
    Bone Marrow Transplant; 2010 Jan; 45(1):195-6. PubMed ID: 19430504
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation; the current renaissance.
    Copelan EA; Chojecki A; Lazarus HM; Avalos BR
    Blood Rev; 2019 Mar; 34():34-44. PubMed ID: 30467067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
    Marks DI; Alonso L; Radia R
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):995-1009. PubMed ID: 25459175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
    Oran B; Champlin RE; Wang F; Tanaka T; Saliba RM; Al-Atrash G; Garcia-Manero G; Kantarjian H; Cao K; Shpall EJ; Alousi AM; Mehta RS; Popat U; Futreal A; Takahashi K
    Leukemia; 2022 Jan; 36(1):257-262. PubMed ID: 34135465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor derived leukemia in allogeneic transplantation.
    Aldoss I; Clark M; Marcucci G; Forman SJ
    Leuk Lymphoma; 2021 Dec; 62(12):2823-2830. PubMed ID: 34713775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
    Marks DI; Wang T; Pérez WS; Antin JH; Copelan E; Gale RP; George B; Gupta V; Halter J; Khoury HJ; Klumpp TR; Lazarus HM; Lewis VA; McCarthy P; Rizzieri DA; Sabloff M; Szer J; Tallman MS; Weisdorf DJ
    Blood; 2010 Jul; 116(3):366-74. PubMed ID: 20404137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Turcotte LM; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Ahmed I; Beitinjaneh A; Buchbinder D; Byrne M; Callander N; Chao N; Choi SW; DeFilipp Z; Gadalla SM; Gale RP; Gergis U; Hashmi S; Hematti P; Holmberg L; Inamoto Y; Kamble RT; Lehmann L; MacMillan MA; McIver Z; Nishihori T; Norkin M; O'Brien T; Olsson RF; Reshef R; Saad A; Savani BN; Schouten HC; Seo S; Solh M; Verdonck L; Vij R; Wirk B; Yared J; Horowitz MM; Knight JM; Verneris MR
    Bone Marrow Transplant; 2018 Jul; 53(7):932-937. PubMed ID: 29382954
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Alternative Donor Allogeneic Transplants in the Therapy of Acute Myeloid Leukemia.
    Elmariah H; Pratz KW
    J Natl Compr Canc Netw; 2017 Jul; 15(7):959-966. PubMed ID: 28687582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
    Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of childhood leukemia with haploidentical hematopoietic stem cell transplantation using parent as donor: a single-center study of 111 case.
    Sun Y; Xiao J; Li ZH; Fan SF; Shen Y
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4379-84. PubMed ID: 26636526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.
    Yu S; Huang F; Fan Z; Xuan L; Nie D; Xu Y; Yang T; Wang S; Jiang Z; Xu N; Lin R; Ye J; Lin D; Sun J; Huang X; Wang Y; Liu Q
    J Hematol Oncol; 2020 Mar; 13(1):18. PubMed ID: 32164760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.
    Wang F; Cai B; Wang L; Gu Z; Luo L; Wei H; Zhao S; Guan L; Wang X; Wang L; Liu D; Gao C
    Ann Transplant; 2017 Feb; 22():58-65. PubMed ID: 28154370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.